adamantane has been researched along with atrial natriuretic factor in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brandt, I; De Meester, I; Ketelslegers, JM; Lambeir, AM; Scharpé, S; Vanderheyden, M | 1 |
| Baines, CP; Burnett, JC; Chakir, K; Cruz Rivera, N; Domeier, TL; Dozier, DG; Emter, CA; Ferguson, BS; Gutiérrez-Aguilar, M; Heublein, DM; Hiemstra, JA; Ivey, JR; Krenz, M; Lee, DI; Marshall, KD; McDonald, KS; Minervini, G; Scherf, C; Zgoda, PJ | 1 |
| Abd El Fattah, MA; Abdallah, DM; El-Abhar, HS; Kamel, NM | 1 |
| Feng, X; Gao, G; Gu, Q; Li, Q; Yuan, L; Zhang, Y | 1 |
1 trial(s) available for adamantane and atrial natriuretic factor
| Article | Year |
|---|---|
The plasma levels of atrial natriuretic peptide and brain natriuretic peptide in type 2 diabetes treated with sodium-glucose cotransporter-2 inhibitor.
Topics: Adamantane; Adolescent; Adult; Aged; Aged, 80 and over; Atrial Natriuretic Factor; Benzhydryl Compounds; Blood Glucose; Diabetes Mellitus, Type 2; Dipeptides; Female; Glucosides; Glycated Hemoglobin; Humans; Insulin; Male; Middle Aged; Natriuretic Peptide, Brain; Sodium-Glucose Transporter 2 Inhibitors; Treatment Outcome; Young Adult | 2020 |
3 other study(ies) available for adamantane and atrial natriuretic factor
| Article | Year |
|---|---|
Dipeptidyl-peptidase IV converts intact B-type natriuretic peptide into its des-SerPro form.
Topics: Adamantane; Atrial Natriuretic Factor; Dipeptides; Dipeptidyl Peptidase 4; Humans; Hydrolysis; In Vitro Techniques; Kinetics; Natriuretic Peptide, Brain; Neprilysin; Nitriles; Peptide Fragments; Protease Inhibitors; Pyrrolidines; Vildagliptin | 2006 |
Saxagliptin and Tadalafil Differentially Alter Cyclic Guanosine Monophosphate (cGMP) Signaling and Left Ventricular Function in Aortic-Banded Mini-Swine.
Topics: Adamantane; Animals; Atrial Natriuretic Factor; Cyclic GMP; Dipeptides; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Echocardiography; Hypertrophy, Left Ventricular; Male; Natriuretic Peptide, Brain; Neuropeptide Y; Phosphodiesterase 5 Inhibitors; Signal Transduction; Swine; Swine, Miniature; Tadalafil; Ventricular Function, Left | 2016 |
Novel repair mechanisms in a renal ischaemia/reperfusion model: Subsequent saxagliptin treatment modulates the pro-angiogenic GLP-1/cAMP/VEGF, ANP/eNOS/NO, SDF-1α/CXCR4, and Kim-1/STAT3/HIF-1α/VEGF/eNOS pathways.
Topics: Adamantane; Animals; Atrial Natriuretic Factor; Cell Adhesion Molecules; Chemokine CXCL12; Cyclic AMP; Dipeptides; Disease Models, Animal; Glucagon-Like Peptide 1; Glutathione; Hypoxia-Inducible Factor 1, alpha Subunit; Kidney; Male; Malondialdehyde; Neovascularization, Physiologic; Nitric Oxide; Nitric Oxide Synthase Type III; Oxidative Stress; Peroxidase; Rats; Rats, Wistar; Receptors, CXCR4; Reperfusion Injury; Signal Transduction; STAT3 Transcription Factor; Vascular Endothelial Growth Factor A | 2019 |